Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetRevenue - OtherRevenue - RentalShares IssuedShares OutstandingShares OutstandingWages, Salaries and Other
Ratios

Maxcyte (MXCT) Shares Issued (2021 - 2026)

Maxcyte has reported Shares Issued over the past 5 years, most recently at $15000.0 for Q4 2025.

  • Quarterly Shares Issued fell 92.27% to $15000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $432000.0 through Dec 2025, down 5.88% year-over-year, with the annual reading at $432000.0 for FY2025, 5.88% down from the prior year.
  • Shares Issued was $15000.0 for Q4 2025 at Maxcyte, up from $14000.0 in the prior quarter.
  • Over five years, Shares Issued peaked at $181.8 million in Q4 2021 and troughed at -$1.4 million in Q4 2023.
  • The 5-year median for Shares Issued is $325500.0 (2022), against an average of $14.0 million.
  • The largest YoY upside for Shares Issued was 114.05% in 2024 against a maximum downside of 378.98% in 2024.
  • A 5-year view of Shares Issued shows it stood at $181.8 million in 2021, then plummeted by 99.33% to $1.2 million in 2022, then tumbled by 212.69% to -$1.4 million in 2023, then soared by 114.05% to $194000.0 in 2024, then plummeted by 92.27% to $15000.0 in 2025.
  • Per Business Quant, the three most recent readings for MXCT's Shares Issued are $15000.0 (Q4 2025), $14000.0 (Q3 2025), and $20000.0 (Q2 2025).